Advisornet Financial’s Cytosorbents Corp CTSO Stock Holding History

Advisornet Financial’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100	Closed	–	–	1916
2022 Q1	$0	Hold	100	–	–	﹤0.01%	2029
2021 Q4	$0	Sell	100 -1,000	-91%	-$5.61K	﹤0.01%	2043
2021 Q3	$9K	Hold	1,100	–	–	﹤0.01%	1479
2021 Q2	$8K	Hold	1,100	–	–	﹤0.01%	1459
2021 Q1	$10K	Hold	1,100	–	–	﹤0.01%	1361
2020 Q4	$9K	Hold	1,100	–	–	﹤0.01%	1307
2020 Q3	$9K	Hold	1,100	–	–	﹤0.01%	1293
2020 Q2	$11K	Hold	1,100	–	–	﹤0.01%	1275
2020 Q1	$9K	Buy	1,100 +1,000	+1,000%	+$5.05K	﹤0.01%	1281
2019 Q4	$0	Hold	100	–	–	﹤0.01%	1872
2019 Q3	$1K	Hold	100	–	–	﹤0.01%	1736
2019 Q2	$1K	Hold	100	–	–	﹤0.01%	1572
2019 Q1	$1K	Hold	100	–	–	﹤0.01%	1480
2018 Q4	$1K	Hold	100	–	–	﹤0.01%	1385
2018 Q3	$1K	Buy	+100	New	+$1.25K	﹤0.01%	1398

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisornet Financial's CTSO Position: Q2 2022 in Review

Advisornet Financial sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 100 shares.

Advisornet Financial first reported a position in CTSO in Q3 2018 and held it in 15 quarters. The position peaked at $11K in Q2 2020. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Advisornet Financial reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Advisornet Financial sold 100 Cytosorbents Corp shares in Q2 2022.
Advisornet Financial first reported a position in Cytosorbents Corp in Q3 2018 and held it in 15 quarters.
Advisornet Financial's Cytosorbents Corp position peaked at $11K in Q2 2020.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Advisornet Financial's 13F filing for Q2 2022, filed 7 Jul 2022.